Results 261 to 270 of about 380,814 (333)
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors. [PDF]
Baars B +13 more
europepmc +1 more source
This study identifies POLD4 as a potential prostate cancer radiosensitization target through transcriptome sequencing. By encapsulating POLD4‐targeted CRISPR/Cas9 plasmids and USPIONs in cationic liposomes, an MRI‐monitored gene‐editing platform is established.
Xuhui Fan +10 more
wiley +1 more source
Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma. [PDF]
Zhou Y +25 more
europepmc +1 more source
Probing the Hotspot Binding Sites of Proteins: P22TSP, Ras and BAF
Mychal Daijon Smith
openalex +1 more source
Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders
Summary on the dual potential of cfDNA as biomarkers and therapeutic targets for inflammatory disorders. Figure was created with BioRender.com. ABSTRACT Inflammatory disorders are characterized by immune‐mediated inflammatory cascades that can affect multiple organs.
Jiatong Li +7 more
wiley +1 more source
Development of a Genetically Encoded and Potent PDE6D Inhibitor. [PDF]
Gómez-Mulas A +7 more
europepmc +1 more source
T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities
T cell exhaustion limits immunotherapy efficacy. This article delineates its progression from stem‐like to terminally exhausted states, governed by persistent antigen, transcription factors, epigenetics, and metabolism. It maps the exhaustion landscape in the TME and proposes integrated reversal strategies, providing a translational roadmap to overcome
Yang Yu +7 more
wiley +1 more source

